TITLE

High Risk of ART Non-Adherence and Delay of ART Initiation among HIV Positive Double Orphans in Kigali, Rwanda

AUTHOR(S)
Kikuchi, Kimiyo; Poudel, Krishna C.; Muganda, John; Majyambere, Adolphe; Otsuka, Keiko; Sato, Tomoko; Mutabazi, Vincent; Nyonsenga, Simon Pierre; Muhayimpundu, Ribakare; Jimba, Masamine; Yasuoka, Junko
PUB. DATE
July 2012
SOURCE
PLoS ONE;Jul2012, Vol. 7 Issue 7, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: To reduce HIV/AIDS related mortality of children, adherence to antiretroviral treatment (ART) is critical in the treatment of HIV positive children. However, little is known about the association between ART adherence and different orphan status. The aims of this study were to assess the ART adherence and identify whether different orphan status was associated with the child's adherence. Methods: A total of 717 HIV positive children and the same number of caregivers participated in this cross-sectional study. Children's adherence rate was measured using a pill count method and those who took 85% or more of the prescribed doses were defined as adherent. To collect data about adherence related factors, we also interviewed caregivers using a structured questionnaire. Results: Of all children (N = 717), participants from each orphan category (double orphan, maternal orphan, paternal orphan, non-orphan) were 346, 89, 169, and 113, respectively. ART non-adherence rate of each orphan category was 59.3%, 44.9%, 46.7%, and 49.7%, respectively. The multivariate analysis indicated that maternal orphans (AOR 0.31, 95% CI 0.12- 0.80), paternal orphans (AOR 0.35, 95% CI 0.14-0.89), and non-orphans (AOR 0.45, 95% CI 0.21-0.99) were less likely to be non-adherent compared to double orphans. Double orphans who had a sibling as a caregiver were more likely to be nonadherent. The first mean CD4 count prior to initiating treatment was 520, 601, 599, and 844 (cells/ml), respectively (p<0.001). Their mean age at sero-status detection was 5.9, 5.3, 4.8, and 3.9 (year old), respectively (p<0.001). Conclusions: Double orphans were at highest risk of ART non-adherence and especially those who had a sibling as a caregiver had high risk. They were also in danger of initiating ART at an older age and at a later stage of HIV/AIDS compared with other orphan categories. Double orphans need more attention to the promote child's adherence to ART.
ACCESSION #
79786012

 

Related Articles

  • Correlates of Adherence to Antiretroviral Therapy in HIV-Infected Children in Lomé, Togo, West Africa. Polisset, Julie; Ametonou, Francine; Arrive, Elise; Aho, Anthony; Perez, Freddy // AIDS & Behavior;Feb2009, Vol. 13 Issue 1, p23 

    We assessed pediatric adherence to antiretroviral therapy (ART) and examined associated factors among children in Togo, West Africa. Structured interviews of caregivers of consecutively enrolled HIV-infected children receiving ART in three HIV/AIDS care centers in Lome, Togo were conducted....

  • Cancer Burden Shifts for People With HIV/AIDS.  // JNCI: Journal of the National Cancer Institute;May2011, Vol. 103 Issue 9, pNP 

    The article discusses the findings of research about the incidence and types of cancer among people with human immunodeficiency virus/acquired immune deficiency syndrome (HIV/AIDS) in the U.S. According to researchers from the National Cancer Institute (NCI) and the Centers for Disease Control...

  • Optimizing Predictive Mining Techniques in HIV-Related Opportunistic Infections: Case for Botswana. Buthu'gwashe; Zhiyong Li; Kirui, Clement // International Journal of Computer Applications;Aug2013, Vol. 76 Issue 1-16, p1 

    Botswana was one of the first countries to establish a national Antiretroviral therapy (ART) programme in Africa. "Masa," a native word depicting "a new dawn," is the programme name. The AIDS epidemic has led to the emergence of several disease entities which in the pre-AIDS era seemed...

  • When to Start Antiretroviral Therapy in Resource-Limited Settings. Rochelle P. Walensky; Lindsey L. Wolf; Robin Wood; Mariam O. Fofana; Kenneth A. Freedberg; Neil A. Martinson; A. David Paltiel; Xavier Anglaret; Milton C. Weinstein; Elena Losina // Annals of Internal Medicine;8/4/2009, Vol. 151 Issue 3, p157 

    Background: The results of international clinical trials that are assessing when to initiate antiretroviral therapy (ART) will not be available for several years. Objective: To inform HIV treatment decisions about the optimal CD4 threshold at which to initiate ART in South Africa while awaiting...

  • Free antiretroviral treatment effective in Malawi.  // Infectious Disease News;Jun2008, Vol. 21 Issue 6, p39 

    The article reports on the results of a study on the efficiency of antiretroviral therapy in Malawi. It revealed that mortality rates of patients with HIV and AIDS have been reduced following the introduction of free antiretroviral therapy. According to researchers, the mortality rate was 9.8...

  • Role of Uncontrolled HIV RNA Level and Immunodeficiency in the Occurrence of Malignancy in HIV-Infected Patients during the Combination Antiretroviral Therapy Era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. Bruyand, Mathias; Thie'baut, Rodolphe; Lawson-Ayayi, Sylvie; Joly, Pierre; Sasco, Annie Jeanne; Mercie', Patrick; Pellegrin, Jean Luc; Neau, Didier; Dabis, François; Morlat, Philippe; Chêne, Geneviève; Bonnet, Fabrice // Clinical Infectious Diseases;10/1/2009, Vol. 49 Issue 7, p1109 

    Background. Human immunodeficiency virus (HIV)-infected patients are at higher risk of malignancies. In addition to traditional determinants, a specific deleterious effect of HIV and immunodeficiency is speculated. We aimed at studying the association between immunological and virological...

  • Enfuvirtide (T-20): A Novel Human Immunodeficiency Virus Type 1 Fusion Inhibitor. Cervia, Joseph S.; Smith, Miriam A. // Clinical Infectious Diseases;10/15/2003, Vol. 37 Issue 8, p1102 

    Describes the development of highly active antiretroviral therapy in reducing the progression of AIDS in HIV-infected patients in the U.S. Improvement of the life expectancy of patients; Conformational changes in the HIV envelope glycoprotein 41; Sensitivity of viral envelope to synthetic...

  • LATE REPORTING AMONG NEWLY REGISTERED PATIENTS FOR ANTI RETROVIRAL THERAPY IN A CENTRAL DISTRICT UJJAIN, INDIA. Khandelwal, Vidit; Sabde, Yogesh D.; Pradhan, Riddhi; Sathsh, Mehta Chandra // National Journal of Community Medicine;Oct-Dec2013, Vol. 4 Issue 4, p624 

    Introduction: Current trends in HIV/AIDS epidemic demand quality and sustainable programs to provide universal access to antiretroviral therapy (ART). The inherent disparities in population subgroups result in changing profiles of ART beneficiaries which are needed to account for with reference...

  • Comparing antiretroviral treatment outcomes between a prospective community-based and hospital-based cohort of HIV patients in rural Uganda. Kipp, Walter; Konde-Lule, Joseph; Rubaale, Tom; Okech-Ojony, Joa; Alibhai, Arif; Saunders, Duncan L. // BMC International Health & Human Rights;2011 Supplement 2, Vol. 11 Issue Suppl 2, p1 

    Background: Improved availability of antiretroviral therapy in sub-Saharan Africa is intended to benefit all eligible HIV-infected patients; however in reality antiretroviral services are mainly offered in urban hospitals. Poor rural patients have difficulty accessing the drugs, making the...

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics